Hearing and facial function outcomes for neurofibromatosis 2 clinical trials

OBJECTIVES: Vestibular schwannomas are the hallmark of neurofibromatosis 2 (NF2), occurring in >95% of patients. These tumors develop on the vestibulocochlear nerve and are associated with significant morbidity due to hearing loss, tinnitus, imbalance, facial weakness, and risk of early mortality...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Plotkin, Scott R., Ardern-Holmes, Simone L., Barker, Fred G., Blakeley, Jaishri O., Evans, D. Gareth, Ferner, Rosalie E., Hadlock, Tessa A., Halpin, Chris
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2013
Gaiak:
Response evaluation in neurofibromatosis and schwannomatosis (REiNS)
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3908336/
https://ncbi.nlm.nih.gov/pubmed/24249803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/01.wnl.0000435746.02780.f6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak